RT Journal Article
SR Electronic
T1 Mapping the human helminthiases: advances and gaps in neglected disease surveillance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.30.20223529
DO 10.1101/2020.10.30.20223529
A1 Catherine G. Schluth
A1 Claire J. Standley
A1 Shweta Bansal
A1 Colin J. Carlson
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.10.30.20223529.abstract
AB Infections with parasitic worms, or helminthiases, are a class of neglected tropical diseases that affect at least one billion people worldwide. While some infections are asymptomatic, others can cause severe health conditions such as blindness, epilepsy, and cancer. The burden of these conditions disproportionately affects people in resource-poor areas, making many helminthiases chronically understudied. Mapping helminth outbreaks, prevalence, and habitats in affected regions can offer valuable insights into the spatial scope and burden of these infections. In this study, we conducted a systematic literature review of 232 helminth species that have been recorded infecting humans. Selected out of 6,829 abstracts, we analyzed 485 mapping studies documenting, inferring, or predicting the spatial scope of 45 helminth species. We use these studies to identify hotspots and coldspots of research effort, to highlight gaps in spatial data for particularly harmful or prevalent species, and to collect information about co-occurrence and syndemics among helminthiases and with other diseases. We finally suggest ways these findings could help direct future mapping studies, and ultimately inform public health interventions in understudied and underfunded regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon publication